Envometinib
Envometinib (Compound B) is a dual-MEK inhibitor that works through Deep Cyclic Inhibition (DCI) . Envometinib has antitumor activity in various in vivo models. Envometinib can be studied in RAS and RAF mutated cancer such as colorectal cancer and melanoma[1].
Product Specifications
CAS Number
[2952542-22-0]
UNSPSC
12352005
Target
MEK
Related Pathways
MAPK/ERK Pathway
Field of Research
Cancer
Smiles
CN(CC(C1=C(OC2=O)C=C(OC(N(C)C)=O)C=C1)=C2CC3=C(C(NS(NC)(=O)=O)=CC=C3)Cl)C
Molecular Formula
C23H27ClN4O6S
Molecular Weight
523.00
References & Citations
[1]Brett Matthew HALL, et al., MEK immune oncology inhibitors and therapeutic uses thereof for treating cancer. WO2025010287A2.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
